Green Pine Capital Partners
VC Fund
Shenzhen, China
Green Pine Capital Partners is a VC fund in Shenzhen focused on Artificial Intelligence and Biotechnology. Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.
- Total investments:
- 207
- Last investment:
- Lead investor:
- 33%
- Fund size:
- $138M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Green Pine Capital Partners invests in
Stages Green Pine Capital Partners invests in
Countries Green Pine Capital Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Angel
- $425k–$7.4M
- Series A
- $1.4M–$92M
- Series B
- $14M–$150M
Investment Focus
Industry
- Artificial Intelligence 30 (14%)
- Biotechnology 28 (14%)
- Health Care 27 (13%)
- Manufacturing 25 (12%)
- Software 24 (12%)
Stage
- Series A 66 (32%)
- Angel 38 (18%)
- Series B 32 (15%)
- Seed 26 (13%)
- Series C 14 (7%)
Country
- China 169 (82%)
- United States 7 (3%)
- Canada 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ciqiong Chen
Managing Director and CFO
|
Managing Director and CFO | Total investments: 0 | Find email | |
Fei Luo
Chairman, Managing Director and General Manager
|
Chairman, Managing Director and General Manager | Total investments: 8 | Find email | |
Aaron Zhang
Partner
|
Partner | Total investments: 0 | Find email | |
Chengcheng Guo
Executive Partner of Changfeng Fund and Investment Director
|
Executive Partner of Changfeng Fund and Investment Director | Total investments: 1 | Find email | |
|
Liu Hao
Founder & Managing Director
|
Founder & Managing Director | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Canchen Technology
|
Canchen Tech is a technology company that focuses on the research and development of cell engineering technology in the life sciences field .The company has developed a system-level virtual organ spatiotemporal dynamic evolution model to construct a cross-scale digital twin system for life data. The platform simulates dynamic interactions frommolecules, cells, tissues to organs, and uses algorithms to simulate and deduce evolutionary processes. Its core business is used for preclinical developmental toxicity evaluation of new drugs, target discovery for rare diseases, and early screening of newborn diseases. This technical approach aims to replace and reduce some traditional in vivo animal experiments through data feedback and virtual simulation. | Angel / Jul 31, 2026 | |
|
Blue Emergence
|
Blue Emergence is a marine technology consumer products company, | Angel / Jul 24, 2026 | |
|
Light Leap
|
Light Leap focuses on the consumer-grade quadruped robot market, aiming to penetrate outdoor scenarios with its "all-terrain mobile chassis" and solve the needs of manual labor such as carrying and assisting movement. | $7.4M / Angel / Jul 13, 2026 | |
|
Shenzhen Bay Island Cell Technology
|
Shenzhen Bay Island Cell Technology is a biological technology company that provides universal cell and genetic-based anticancer medicines. | $20.6M / Series A / Jul 10, 2026 | |
|
Zeta Fusion
|
Zeta Fusion operates within the technology promotion and application services industry. | Angel / Jul 09, 2026 | |
|
Guangxiang Technology
|
Guangxiang Technology is dedicated to empowering industrial scenarios through embodied intelligence technology. The company has developed a general-purpose embodied intelligence development platform, centered around its core GOPS platform, to drive innovation and intelligent transformation in industrial applications. | Seed / Jul 04, 2026 | |
Perception Era
|
Perception Era is dedicated to creating a general artificial intelligence assistant through the integration of large model technology with hardware and software platforms. | Angel / Jul 01, 2026 | |
Getai Aviation Technologies Co., Ltd.
|
Getai Aviation Technologies Co., Ltd. designs and manufactures avionics equipment for aerospace industry. | $14.7M / Series A / Jun 24, 2026 | |
Artivila Therapeutics
|
Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform,providing first-in-class new molecules consistently and efficiently.Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China. | $14.7M / Series A / Jun 23, 2026 | |
|
Dayan Technology
|
Dayan Technology develops AI models for 4D world reconstruction and controllable generative simulation. | Angel / Jun 23, 2026 | |
| See all 207 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Green Pine Capital Partners invest in?
Green Pine Capital Partners invests primarily in Artificial Intelligence, Biotechnology and Health Care startups, most often at Series A and Angel stage. Most of the 207 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Green Pine Capital Partners's check size?
Green Pine Capital Partners typically joins rounds of $425k–$7.4M at Angel, $1.4M–$92M at Series A and $14M–$150M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Green Pine Capital Partners participates in.
How do I contact Green Pine Capital Partners?
Public channels for Green Pine Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Green Pine Capital Partners?
The team at Green Pine Capital Partners includes Ciqiong Chen (Managing Director and CFO), Fei Luo (Chairman, Managing Director and General Manager) and Aaron Zhang (Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
